{"id":"chromogranin-a","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Chromogranin A is an acidic secretory protein released by neuroendocrine cells and tumors. It serves as a diagnostic and prognostic biomarker for neuroendocrine neoplasms, carcinoid tumors, and pheochromocytomas, helping clinicians detect, monitor, and assess disease burden and treatment response. It is not a drug that acts on a molecular target but rather a measured biomarker in blood or tissue.","oneSentence":"Chromogranin A is a neuroendocrine biomarker protein used for diagnostic and prognostic assessment rather than a therapeutic agent with a direct mechanism of action.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:43:28.722Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diagnostic and prognostic biomarker for neuroendocrine neoplasms"},{"name":"Monitoring of carcinoid tumors and pheochromocytomas"}]},"trialDetails":[{"nctId":"NCT07364435","phase":"NA","title":"Effect of Bed Bathing Methods on VRE Colonization in ICU Patients","status":"COMPLETED","sponsor":"Özkan Kasap","startDate":"2024-09-01","conditions":"Vancomycin-Resistant Enterococcus","enrollment":210},{"nctId":"NCT06406387","phase":"","title":"ATRX/DAXX in EUS-FNB Specimens of Pan-NETs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2024-06-01","conditions":"Pancreatic Neuroendocrine Tumor","enrollment":100},{"nctId":"NCT03017794","phase":"","title":"Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-01-04","conditions":"Prostate Cancer","enrollment":118},{"nctId":"NCT00799812","phase":"PHASE3","title":"Test for Pre Operative Skin Preparations","status":"COMPLETED","sponsor":"C. R. Bard","startDate":"2007-11-13","conditions":"Topical Antisepsis","enrollment":335},{"nctId":"NCT07209644","phase":"","title":"Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-11-01","conditions":"Systemic Sclerosis","enrollment":70},{"nctId":"NCT07158125","phase":"","title":"Pathogenesis of Periodontal Disease in Individuals With Psoriasis","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2025-09-15","conditions":"Psoriasis","enrollment":60},{"nctId":"NCT07116317","phase":"","title":"Salivary Stress Markers Associated With Malocclusion Severity","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2025-08-11","conditions":"Malocclusion","enrollment":120},{"nctId":"NCT00475930","phase":"NA","title":"Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates","status":"COMPLETED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2007-05","conditions":"Staphylococcus Aureus, Community-acquired Infections, Staphylococcal Skin Infections","enrollment":1563},{"nctId":"NCT07054398","phase":"NA","title":"Assessment of Serum Catestatin Level in Acne Vulgaris Patients","status":"RECRUITING","sponsor":"Aswan University","startDate":"2025-01-10","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT02258412","phase":"PHASE4","title":"Evaluation of Two Hand Hygiene Products in ICUs","status":"COMPLETED","sponsor":"Solventum US LLC","startDate":"2014-10","conditions":"Hand Hygiene Effectiveness","enrollment":51},{"nctId":"NCT03681990","phase":"PHASE2","title":"In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area","status":"COMPLETED","sponsor":"Solventum US LLC","startDate":"2017-06-06","conditions":"Surgical Skin Preparation, Surgical Procedure, Unspecified","enrollment":28},{"nctId":"NCT05712434","phase":"NA","title":"Chlorhexidine to Prevent Catheter-related Urinary Tract Infection","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2023-03-01","conditions":"Urinary Tract Infections","enrollment":30994},{"nctId":"NCT03288402","phase":"NA","title":"Investigation of the Effects of Diet on the Measurement of Plasma Chromogranin in NET Patients","status":"COMPLETED","sponsor":"University Hospitals Coventry and Warwickshire NHS Trust","startDate":"2017-02-01","conditions":"Neuroendocrine Tumors","enrollment":346},{"nctId":"NCT06183047","phase":"","title":"Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT","status":"COMPLETED","sponsor":"Military Institute od Medicine National Research Institute","startDate":"2016-10-01","conditions":"Early Release of Chromogranin A (CgA)","enrollment":38},{"nctId":"NCT06069076","phase":"","title":"Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2023-11-01","conditions":"Diabetic Kidney Disease","enrollment":92},{"nctId":"NCT03385304","phase":"PHASE4","title":"Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2018-04-08","conditions":"Surgical Site Infection, Unplanned Fracture-Related Reoperation, Open Appendicular Fracture","enrollment":1638},{"nctId":"NCT03817866","phase":"","title":"Chromogranin A as Blood Marker in Cancer Patients","status":"COMPLETED","sponsor":"Brahms AG","startDate":"2019-01-29","conditions":"Gastric Neoplasms, Pancreatic Neoplasms, Small Intestinal Neoplasms","enrollment":175},{"nctId":"NCT05297630","phase":"","title":"Comparative Evaluation of the Evolution of Emerging Biological Markers in Patients Hospitalized for Acute Heart Failure According to Conventional Management or Therapeutic Adjustment Via Daily Ultrasound.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2022-02-15","conditions":"Heart Failure","enrollment":169},{"nctId":"NCT04517136","phase":"","title":"Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions","status":"UNKNOWN","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2020-09-14","conditions":"Covid19, SARS-CoV Infection, Burnout, Caregiver","enrollment":39},{"nctId":"NCT03887299","phase":"PHASE4","title":"Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2019-04-18","conditions":"Cesarean Section Complications, Wound Breakdown, Wound Infection","enrollment":154},{"nctId":"NCT02831816","phase":"PHASE3","title":"Clinical Evaluation of Patient Preoperative Prep","status":"COMPLETED","sponsor":"Zurex Pharma, Inc.","startDate":"2016-08-03","conditions":"Surgical Skin Preparation","enrollment":640},{"nctId":"NCT02216227","phase":"NA","title":"Checklist to Prevent MRSA Surgical Site Infections","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2014-04-01","conditions":"Surgical Site Infection","enrollment":1794},{"nctId":"NCT01313273","phase":"PHASE3","title":"Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients","status":"TERMINATED","sponsor":"Ipsen","startDate":"2011-06","conditions":"Prostate Cancer","enrollment":3},{"nctId":"NCT03389386","phase":"","title":"Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure","status":"COMPLETED","sponsor":"Josko Bozic","startDate":"2018-01-25","conditions":"Heart Failure，Congestive","enrollment":120},{"nctId":"NCT03689231","phase":"","title":"Volumetric Imaging Follow up of Patients With Liver Metastases of Small Intestinal Neuroendocrine Tumors (NETs).","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2018-03-01","conditions":"Neuroendocrine Tumors, Liver Metastases","enrollment":80},{"nctId":"NCT00227136","phase":"PHASE3","title":"Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion","status":"TERMINATED","sponsor":"University of Western Ontario, Canada","startDate":"2005-05","conditions":"Carcinoid Tumors, Neuroendocrine Tumors","enrollment":8},{"nctId":"NCT03336957","phase":"NA","title":"Stress and Gingival Inflammation in Non-pregnant and Pregnant Women","status":"COMPLETED","sponsor":"Tokat Gaziosmanpasa University","startDate":"2016-06-01","conditions":"Periodontal Diseases, Pregnancy Gingivitis","enrollment":2},{"nctId":"NCT03200743","phase":"","title":"Catestatin and Hypertension in Pregnancy","status":"UNKNOWN","sponsor":"Yuchen Pan","startDate":"2017-05-14","conditions":"Pre-Eclampsia, Eclampsia, Hypertension, Pregnancy-Induced","enrollment":400},{"nctId":"NCT02500758","phase":"NA","title":"Effectiveness of Preoperative Surgical Scrubbing Using Clorhexidine Digluconate and Parachlorometaxylenol (ECP)","status":"COMPLETED","sponsor":"Ricardo Becerro de Bengoa Vallejo","startDate":"2015-06","conditions":"Skin Diseases, Surgical Site Infection","enrollment":30},{"nctId":"NCT02221232","phase":"PHASE2","title":"Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™","status":"TERMINATED","sponsor":"Zurex Pharma, Inc.","startDate":"2014-08","conditions":"Surgical Site Infection","enrollment":64},{"nctId":"NCT02296645","phase":"PHASE2","title":"Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)","status":"COMPLETED","sponsor":"Zurex Pharma, Inc.","startDate":"2014-11","conditions":"Surgical Site Infection","enrollment":36},{"nctId":"NCT02759718","phase":"PHASE4","title":"Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2012-06","conditions":"Non Functioning Pancreatic Endocrine Tumor","enrollment":111},{"nctId":"NCT02620696","phase":"PHASE1","title":"Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin","status":"COMPLETED","sponsor":"Trio Medicines Ltd.","startDate":"2009-11","conditions":"ECL-cell Hyperplasia, Parietal-cell Hyperplasia, Rebound Hyperacidity","enrollment":48},{"nctId":"NCT00739583","phase":"PHASE4","title":"Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2008-08","conditions":"Arthroplasty, Replacement, Hip","enrollment":20},{"nctId":"NCT01216267","phase":"NA","title":"Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples","status":"COMPLETED","sponsor":"University of Western Ontario, Canada","startDate":"2010-06","conditions":"Neuroendocrine Carcinoma (Carcinoid)","enrollment":200},{"nctId":"NCT00166725","phase":"PHASE2","title":"Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-02","conditions":"Prostate Cancer","enrollment":40},{"nctId":"NCT00399620","phase":"NA","title":"Chromogranin-A-Derived Peptides and Periodontitis in Diabetic Patients","status":"UNKNOWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2008-03","conditions":"Periodontitis and Diabetitis","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CgA"],"phase":"marketed","status":"active","brandName":"Chromogranin A","genericName":"Chromogranin A","companyName":"Asan Medical Center","companyId":"asan-medical-center","modality":"Biologic","firstApprovalDate":"","aiSummary":"Chromogranin A is a neuroendocrine biomarker protein used for diagnostic and prognostic assessment rather than a therapeutic agent with a direct mechanism of action. Used for Diagnostic and prognostic biomarker for neuroendocrine neoplasms, Monitoring of carcinoid tumors and pheochromocytomas.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}